NeuroSense Therapeutics (NRSN) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
NRSN is expected to report earnings to fall 24.32% to -14 cents per share on November 27
Q3'24
Est.
$-0.14
Q2'24
Est.
$-0.19
Q1'24
Missed
by $0.14
Q4'23
Beat
by $0.02
Q3'23
Beat
by $0.31
The last earnings report on August 28 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 100.10K shares outstanding, the current market capitalization sits at 24.92M.